Bob Hamm of Cambridge, Mass.-based Biogen has been named senior vice president for North American commercial operations, the company announced in December. Hamm, who has been with Biogen since 1994, was Biogen’s senior vice president for Europe, Canada and the Middle East. He will report to Hans Peter Hasler, executive vice president.
Peter Jensen, has been named as non-executive director of Genetix of New Milton, UK. Jensen is chairman of the European Business Forum and serves as a director of Domino Printing Sciences and Newmarket Racecourses Trust. Previously, Jensen was chairman of SmithKlineBeecham’s European consumer healthcare operations and then president of worldwide supply operations.
Ken Thornton has been named to the board of directors of First Genetic Trust, a Deerfield, Ill., bioinformatics technology company. Thornton is a retired IBM executive, serving as general manager, public sector and as a member of the company’s worldwide management and corporate technology councils.
Jack Dixon will become dean for scientific affairs and health sciences at the University of California, San Diego, in February, following George Palade, who retired about a year ago. Dixon currently directs the life sciences institute at the University of Michigan. In California, he will be professor of pharmacology and of cellular and molecular medicine.
Yury Rozenman leaves as director of life science business development at Platform Computing to join IBM as global pharmaceutical marketing manager.